Standout Papers

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephr... 2001 2026 2009 2017 4.2k
  1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes (2001)
    Edmund J. Lewis, Lawrence G. Hunsicker et al. New England Journal of Medicine
  2. The Rising Prevalence of Diabetes and Impaired Glucose Tolerance (2002)
    David W. Dunstan, Paul Zimmet et al. Diabetes Care
  3. Prevalence of Kidney Damage in Australian Adults (2003)
    Steven J. Chadban, Esther M. Briganti et al. Journal of the American Society of Nephrology

Immediate Impact

3 by Nobel laureates 3 from Science/Nature 113 standout
Sub-graph 1 of 13

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
2023 Standout

Works of Robert C. Atkins being referenced

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout

Author Peers

Author Last Decade Papers Cites
Robert C. Atkins 7474 2766 2219 4236 3690 238 17.5k
Seiichi Matsuo 6770 2030 2676 3159 1732 322 17.3k
Piero Ruggenenti 7713 1307 2595 3518 2393 216 14.1k
Danilo Fliser 6398 1846 2218 4185 1649 298 18.0k
Edmund J. Lewis 8768 1603 2328 7654 5484 161 17.9k
Enyu Imai 7299 907 2506 3541 2257 322 18.3k
Ravi Thadhani 8912 3878 2803 2730 1494 292 29.6k
David A. Roth 6488 2271 2874 4080 1568 208 20.2k
Francesco Locatelli 12956 1736 3099 3062 1621 524 24.5k
Masaomi Nangaku 8139 2377 2250 2344 3049 700 23.3k
Barry I. Freedman 6024 756 1224 2537 3081 415 15.9k

All Works

Loading papers...

Rankless by CCL
2026